A Strategy Framwork For Deciding Between Alliances Or Acquisition Of Johnson & Johnson Pharmaceutical Company (Case Study: Strategy Farmwork of Johnson & Johnson And Cipla Inc in The Production of Anti-Infectious Drugs)
DOI:
https://doi.org/10.21580/jdmhi.2019.1.1.4730Keywords:
Strategy Framwork, Alliance and Acquisition, Anti-Infectious DrugsAbstract
This study analyzes a strategy framwork for deciding between alliances or acquisition of Johnson & Johnson Pharmeutical Company. The general objective of this study is to determine the appropriate corporate development strategy of Johnson & Johnson to strengthening the position in the area of infectious diseasese to help the mankind to get the best anti infectious drugs with the affordable price. Infectious diseases is a second leading killer worldwide, it is consist of HIV/ AIDS, TB, Hepatitis C, etc. Infectious diseases have caused an unprecedented global health crisis. The Asia division of Johnson & Johnson plans to invest in open innovation through more research partnerships and collaborative efforts that connect the medical and academic communities to its R&D centers especially in infectious disease. The data used in this research is data result of observation, literature study and interviews with senior executives and consultants who handle comparable decision of Johnson&Johnson. The data show that alliance is preferrable. High uncertainty within the environment is the most influencing factor to determine this choice. Due to the industry nature, many R&D collaborations in developing particular drugs are established. By defining the proper governance structure the collaboration can limit the risk of losing in the learning race and core competencies spillover while obtaining the knowledge access to the counterparty. The Strategic alliance between Johnson & Johnson and Cipla Inc can help them toughen the corporate development strategy. Because of their similarities in the production of anti-infectious drugs, they can cooperate to penetrate emerging markets and do several R&D collaborations to create a competitive advantage.
Downloads
References
Aaker, David A. (2013). Manajemen Pemasaran Strategi. Edisi ke delapan. Salemba Empat. Jakarta. About.com. (2011). Culture: Your Environment for People at Work.(http://humanresources.about.com/od/organizationalculture/a/culture.htm. Retrieved November 8, 2018).
Advantage Business Media. (2009, June 12). J&J Opens R&D Center in Shanghai. (http://www.dddmag.com/news-JJ-Opens-RD-Center-in-Shanghai-061209.aspx America’s Biotechnology Research Companies. 2010. Medicines in Development for AIDS. Retrieved November 2, 2018, from Drug Discovery & Development).
Answer Corporation. (2017). Cipla Limited. (http://www.answers.com/topic/cipla. Retrieved November 13, 2018).
Avert. (2011). News. (http://www.avert.org/new-aids-drugs.htm. Retrieved November 5, 2018)
Bloomberg. (2011). News. (http://www.bloomberg.com/news/2011-05-23/j-j-aids-pill-signals-9-billion-in-sales-to-ease-recall-woes.html. Retrieved November 2, 2018).
Brackman, S., Garretsen, H., & van Marrewijk, C. (2006). Cross Border Mergers & Acquisitions: The Facts as a Guide for International Economics, CESifo Working Paper: CESifo.
Cartwright, S. & Schoenberg, R. (2006). Thirty Years of Mergers and Acquisitions Research: Recent Advances and Future Opportunities. British Journal of Management, 17: 1-5.
Cipla. (n.d.). Code of conduct. (http://www.cipla.com/corporateprofile/code_of_conduct.htm. Retrieved November 8, 2011).
Cummings, Stevan R. Holmberg and Jeffrey L.(2009). Building Successful Strategic Alliances. Long Range Planning, 42(2):164-193.
Das and Teng. (2000). A Resource-Based Theoryof Strategic Alliances. Journal of Management 2000, Vol. 26, No. 1, 31–61.
Grant RM, Baden-Fuller C.(2004). A knowledge accessing theory of strategic alliances. Journal of Management Studies,41:61–84
Hoffman and Schlosser. (2000). Success Factors of Strategic Alliances in Small- and Medium-sized Enterprises: An Empirical Survey. Long Range Planning.
Hoffmann, W.H. & Schaper-Rinkel W. (2001). Acquire or Ally? –A strategy framework for deciding between acquisition and cooperation. Management International Review, 41: 131-159.
Hospitalharma.2010. Corporate Information. Tibotec and JJ Cleared to Launch Aptivus Rival , (http://www.hospitalpharma.com/features/feature.asp?ROW_ID=847. Retrieved November,5, 2018)
Downloads
Published
Issue
Section
License
The copyright of the received article shall be assigned to the journal as the publisher of the journal. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
The work under license Creative Commons Attribution-ShareAlike 4.0 International License.
.png)
